一个参与的过程来设计一个应用程序,以提高对抗骨质疏松症治疗的坚持:一个开发和可用性研究
Alessandra Angelucci1, Benedetta Pongiglione2, Sara Bernasconi1
1Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Digital health
|December 18, 2023
概括
开发了一个新的应用程序,以改善骨质疏松症治疗的坚持. 虽然可行,但以患者为中心的性能在可用性测试期间低于可行性测试.
科学领域:
- 数字健康数字健康
- 骨质疏松症管理管理
- 患者的坚持 患者的坚持
背景情况:
- 骨质疏松症需要长期坚持治疗才能有效.
- 移动健康 (mHealth) 应用程序有可能改善患者的患者执法.
- 开发以用户为中心的移动健康工具对于成功实施至关重要.
研究的目的:
- 开发和评估一个移动应用程序的可用性,旨在提高骨质疏松症患者的药物坚持.
- 评估患者和专家在应用程序开发过程中的投入.
主要方法:
- 通过聚焦小组和与骨质疏松症患者和骨专家的采访进行代应用程序开发.
- 在13-25天内对8名患者进行可行性测试.
- 在六个月内对9名患者进行可用性测试,使用mHealth App可用性问卷 (MAUQ).
主要成果:
- 最终的应用程序包括骨质疏松症信息,专家联系,药物提醒和坚持反.
- 整体应用程序评估是积极的,但可行性测试比可用性测试得出了明显更好的MAUQ分数.
- 可用性测试表明,与可行性阶段相比,以患者为中心的表现较低.
结论:
- 开发的应用程序有望改善骨质疏松症治疗的坚持.
- 需要进一步改进,以增强应用程序的以患者为中心的方面.
- 未来的研究应该扩大参与者队列,并在可用性测试期间纳入技术支持.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
728
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
728
01:40Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
01:26Drug Administration and Therapy Phases: Overview
476
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
476
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:24Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation
1.2K
Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
1.2K
01:29Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K